These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 33704423)

  • 1. CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Gallups NJ; Standaert DG; Harms AS
    Brain; 2021 Aug; 144(7):2047-2059. PubMed ID: 33704423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
    Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
    J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease.
    Theodore S; Cao S; McLean PJ; Standaert DG
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1149-58. PubMed ID: 19018246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHCII is required for α-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration.
    Harms AS; Cao S; Rowse AL; Thome AD; Li X; Mangieri LR; Cron RQ; Shacka JJ; Raman C; Standaert DG
    J Neurosci; 2013 Jun; 33(23):9592-600. PubMed ID: 23739956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson's disease mice.
    Karikari AA; McFleder RL; Ribechini E; Blum R; Bruttel V; Knorr S; Gehmeyr M; Volkmann J; Brotchie JM; Ahsan F; Haack B; Monoranu CM; Keber U; Yeghiazaryan R; Pagenstecher A; Heckel T; Bischler T; Wischhusen J; Koprich JB; Lutz MB; Ip CW
    Brain Behav Immun; 2022 Mar; 101():194-210. PubMed ID: 35032575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the JAK/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson's disease.
    Hong H; Wang Y; Menard M; Buckley JA; Zhou L; Volpicelli-Daley L; Standaert DG; Qin H; Benveniste EN
    J Neuroinflammation; 2024 Sep; 21(1):216. PubMed ID: 39218899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
    Galiano-Landeira J; Torra A; Vila M; Bové J
    Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune system in Parkinson's disease: what we know so far.
    Roodveldt C; Bernardino L; Oztop-Cakmak O; Dragic M; Fladmark KE; Ertan S; Aktas B; Pita C; Ciglar L; Garraux G; Williams-Gray C; Pacheco R; Romero-Ramos M
    Brain; 2024 Oct; 147(10):3306-3324. PubMed ID: 38833182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
    Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
    Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease.
    Williams GP; Marmion DJ; Schonhoff AM; Jurkuvenaite A; Won WJ; Standaert DG; Kordower JH; Harms AS
    Acta Neuropathol; 2020 May; 139(5):855-874. PubMed ID: 31993745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets.
    Reynolds AD; Stone DK; Mosley RL; Gendelman HE
    J Immunol; 2009 Apr; 182(7):4137-49. PubMed ID: 19299711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models.
    La Vitola P; Balducci C; Baroni M; Artioli L; Santamaria G; Castiglioni M; Cerovic M; Colombo L; Caldinelli L; Pollegioni L; Forloni G
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):43-60. PubMed ID: 32696999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson's disease mice.
    Badr M; McFleder RL; Wu J; Knorr S; Koprich JB; Hünig T; Brotchie JM; Volkmann J; Lutz MB; Ip CW
    J Neuroinflammation; 2022 Dec; 19(1):319. PubMed ID: 36587195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease.
    Iba M; Kwon S; Kim C; Szabo M; Horan-Portelance L; Lopez-Ocasio M; Dagur P; Overk C; Rissman RA; Masliah E
    J Neuroinflammation; 2024 Apr; 21(1):93. PubMed ID: 38622654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and regulation of CD4
    Sun X; Gu R; Bai J
    Cell Mol Life Sci; 2024 Aug; 81(1):352. PubMed ID: 39153043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring autoantibodies against α-synuclein rescues memory and motor deficits and attenuates α-synuclein pathology in mouse model of Parkinson's disease.
    Huang YR; Xie XX; Ji M; Yu XL; Zhu J; Zhang LX; Liu XG; Wei C; Li G; Liu RT
    Neurobiol Dis; 2019 Apr; 124():202-217. PubMed ID: 30481547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice.
    Earls RH; Menees KB; Chung J; Barber J; Gutekunst CA; Hazim MG; Lee JK
    J Neuroinflammation; 2019 Dec; 16(1):250. PubMed ID: 31796095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response.
    Wang M; Sun F; Han X; Wang N; Liu Y; Cai J; Tong S; Wang R; Wang H
    Mol Neurobiol; 2024 Jan; 61(1):252-265. PubMed ID: 37603153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.